We analyzed the abundance of KC subcluster 6, with CD62L as a marker, in murine livers by flow cytometry and IF analyses, and found that CD62L+ KCs were obviously enriched in LvM16-inoculated livers compared to tumor-free tissues or those with non-metastatic cancer cells (Fig. 2g, h), consistent with the scRNA-seq analysis. The gene discussed is SELL; the disease is neoplasm.